Abstract Details
|
Pietro Guaraldi, MD, PhD
(IRCCS Istituto Delle Scienze Neurologiche Di Bologna)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Giovanna Calandra-Buonaura | No disclosure on file |
| Gretchen E. Tietjen, MD (University of Toledo) | An immediate family member of Dr. Tietjen has stock in Johnson & Johnson. |
| Chiara La Morgia, MD (University of Bologna) | Dr. La Morgia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regulatory Pharmanet s.r.l. . Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Santhera Pharmaceuticals. Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi Farmaceutici s.p.a.. The institution of Dr. La Morgia has received research support from Italian Ministry of Health. |
| Valerio Carelli, MD, PhD (University of Bologna) | Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici. |
| No disclosure on file | |
| No disclosure on file | |
| Pietro Cortelli, MD, FAAN | Dr. Cortelli has nothing to disclose. |
| No disclosure on file |